key: cord-0856151-58qneoj5
authors: Olabi, Bayanne; Bagaria, Jayshree; Bhopal, Sunil S.; Curry, Gwenetta D.; Villarroel, Nazmy; Bhopal, Raj
title: Population perspective comparing COVID-19 to all and common causes of death during the first wave of the pandemic in seven European countries
date: 2021-01-15
journal: Public Health Pract (Oxf)
DOI: 10.1016/j.puhip.2021.100077
sha: c39954cc7c903e1bb464270307c8a3c90cbf40c1
doc_id: 856151
cord_uid: 58qneoj5

OBJECTIVES: Mortality statistics on the COVID-19 pandemic have led to widespread concern and fear. To contextualise these data, we compared mortality related to COVID-19 during the first wave of the pandemic across seven countries in Europe with all and common causes of death, stratifying by age and sex. We also calculated deaths as a proportion of the population by age and sex. STUDY DESIGN: Analysis of population mortality data. METHODS: COVID-19 related mortality and population statistics from seven European countries were extracted: England and Wales, Italy, Germany, Spain, France, Portugal and Netherlands. Available data spanned 14–16 weeks since the first recorded deaths in each country, except Spain, where only comparable stratified data over an 8-week time period was available. The Global Burden of Disease database provided data on all deaths and those from pneumonia, cardiovascular disease combining ischaemic heart disease and stroke, chronic obstructive pulmonary disease, cancer, road traffic accidents and dementia in 2017. RESULTS: Deaths related to COVID-19, while modest overall, varied considerably by age. Deaths as a percentage of all cause deaths during the time period under study ranged from <0.01% in children in Germany, Portugal and Netherlands, to as high as 41.65% for men aged over 80 years in England and Wales. The percentage of the population who died from COVID-19 was less than 0.2% in every age group under the age of 80. In each country, over the age of 80, these proportions were: England and Wales 1.27% males, 0.87% females; Italy 0.6% males, 0.38% females; Germany 0.13% males, 0.09% females; France 0.39% males, 0.2% females; Portugal 0.2% males, 0.15% females; and Netherlands 0.6% males, 0.4% females. CONCLUSIONS: Mortality rates from COVID-19 during the first wave of the pandemic were low including when compared to other common causes of death and are likely to decline further while control measures are maintained, treatments improve and vaccination is instituted. These data may help people to contextualise their risk and for decision-making by policymakers.

The COVID-19 pandemic, calamitous though it is, needs to be placed in perspective. It has been 12 months since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak was first identified [1] , and deaths globally continue to rise. As of November 30, 2020, there have been an estimated 62, 195, 274 cases and 1,453,355 directly attributable deaths worldwide [2] . These are undoubtedly underestimates. These statistics have caused widespread concern and fear [3, 4] . Some of this concern is clearly justified, but someas we have demonstrated in childrenis disproportionate, given that COVID-19 caused a small fraction of deaths in people under 18-years of age, even fewer than influenza [5] .

Contextualising the impact of COVID-19 in relation to other causes of death, and to mortality rates in the population, helps to gain perspective. Total mortality related to COVID-19 is the most commonly reported statistic, which has been invaluable in galvanising public health interventions [6] ; however, given important differentials by age and sex, stratifying the mortality data is essential [7] .

We report age-and sex-stratified mortality data related to COVID-19 and compare these with all-cause and common causes of mortality using data from the Global Burden of Disease (GBD) study [8] . We examined two perspectives: firstly, mortality from COVID-19 and other common causes of death as a fraction of all deaths, and secondly, as a fraction of the population.

We extracted population size and COVID-19 mortality by age and sex from the National Institute for Demographic Studies website [9] for the following countries: England and Wales, Italy, Germany, Spain, France, Portugal and Netherlands. These countries were selected due to data availability, reporting comparable age groupings stratified by sex, and comparability of location in Western Europe, with reasonably similar health care systems, economy and capacity to collect data. Available data spanned 14-16 weeks since the first recorded deaths in each country, except Spain, where only comparable stratified data over an 8-week time period was available. Furthermore, these countries have had high death rates given their average age of the population is high compared with low-and middle-income countries. These countries, therefore, exemplify the impact of the pandemic at the higher end of the scale of mortality. Most other countries, especially with younger populations, can anticipate lower mortality.

We extracted annual age-and sex-specific death counts from the Global Burden of Disease 2017 study [8] for all causes and pneumonia, cardiovascular disease combining ischaemic heart disease and stroke (CVD), chronic obstructive pulmonary disease (COPD), cancer, road traffic accidents (RTA) and dementia; these six causes were selected as they represent common causes of death in adults [10] . As we have already reported similar analyses in children and young people [5] , and the causes of death are very different from adults, we only compare COVID-19 and all-cause mortality.

To compare mortality estimates from the GBD with those from COVID-19, mortality rates for non-COVID-19 causes for each country were adjusted based on the number of weeks that COVID-19 data were available for (Supplementary Table 1 ).

Data were analysed by country, age and sex with deaths related to COVID-19 and to other specific causes as a fraction of both all causes of death and population size. Data extraction and analysis was carried out by BO and checked independently by JB. Butterfly charts with stacked bars display these data graphically. Table 1 shows mortality by cause, age and sex in the seven countries from March 09, 2020 until July 09, 2020 (for specific dates see Supplementary Table 1 ) and the percentage of COVID-19 deaths and other causes of death with respect to all-cause mortality. Fig. 1 summarises these data.

Across all countries the number of deaths related to COVID-19 demonstrated a sharp increase with age, and there were greater numbers of deaths in males than females. Deaths related to COVID-19 represented a small proportion of all deaths overall, though this varied considerably by age being less than 0.01% in children in Germany, Portugal and Netherlands, and as high as 41.65% for men aged over 80 years in England and Wales. In groups under the age of 70, COVID-19 was never the commonest cause of death although it was an important contributor. Figure 1 provides continuous x-axes to 100%). These figures show that, cumulatively, mortality from the six common causes of death was less than 1% in every age group, except in those aged over 80 years, where this percentage ranged from 1 to 4%. The percentage of the population dying from COVID-19 was less than 0.2% in every age group under the age of 80 across all countries, less than or equal to 0.1% under the age of 70 and less than 0.04% under the age of 60. In each country, over the age of 80, these proportions were: England and Wales 1.27% males, 0.87% females; Italy 0.6% males, 0.38% females; Germany 0.13% males, 0.09% females; France 0.39% males, 0.2% females; Portugal 0.2% males, 0.15% females; and Netherlands 0.6% males, 0.4% females.

Graphical representation of the data from Spain are shown in Supplementary Figure 2 , as these represent on an 8-week time period, compared to other countries, which represent data over 14-16 weeks.

The COVID-19 pandemic is an international emergency warranting a comprehensive, medical, public health and economic response [11] . Our methods and analyses provide a population perspective on the pandemic during the first wave in, some of the worst affected countries in the world. It is unlikely that the patterns will change in the second wave but they may in subsequent waves given successful vaccination programmes, which are likely to reduce mortality substantially in older age groups. These data show that the high level of mortality is primarily seen in older adults, particularly men. However, even in the most affected groups, other causes of death were more common than COVID-19, and in all groups under the age of 70, COVID-19 did not represent the most common cause of death. Our non-COVID-19 mortality data from the Global Burden of Disease 2017 study allowed us to estimate deaths for different age groups. Given the potential impact of lockdowns on access to healthcare, particularly for those with chronic conditions, it is likely that mortality patterns from these other causes will change in this pandemic year, most likely with increases in cardiovascular diseases and cancer but possibly reductions in infectious diseases including influenza.

These data also highlight the very small percentages of deaths related to COVID-19 relative to population size, representing less than 0.2% in all groups under the age of 80. Mortality related to the first wave of the COVID-19 pandemic in Europe mainly occurred during the months of March, April and May and was subsequently brought under greater control during the summer months. We cannot forecast population impact on mortality patterns of future and waves of the pandemic. We can see, however, the population impact on mortality during the first wave has been modest except in those over 80 years of age. In the immediate future, the relative proportions of deaths from COVID-19 compared to other causes in these European countries are likely to decline as control measures, while being relaxed, are likely to be applied partially and intermittently for some years. Better treatments and widespread vaccination are also likely to reduce COVID-19 mortality.

Mortality related to COVID-19 is known to be higher in males than in females and higher in older age groups and the mechanisms for these differential effects have been postulated [12, 13] . Other important factors have also been recognised to lead to poorer outcomes following COVID-19 infection, including co-morbidity [14] and ethnicity, with data suggesting that ethnic minority groups are at increased risk of death from COVID-19 [15] . Though these have not been analysed in this study, ensuring a holistic approach when determining and addressing risk is important.

We acknowledge limitations of this study. We found variations between countries in proportions of deaths but have not emphasised them as data collection factors may contribute to this. For example, the COVID-19 mortality data from France represented only in-hospital deaths, whereas England and Wales also counted community deaths, including hospices, care homes and patients' homes [9] . A further limitation is that data from Spain only represented an 8-week time span during the initial outbreak, as their data reporting methods changed beyond May [9] , hindering access to comparable data since then. Defining COVID-19 mortality rates is also contentious, as data pertains to clinically apparent PCR-positive infections, underestimating true mortality [16] .

Furthermore, there may be several reasons why the mortality totals exceed 100 in England and Wales, Italy and Spain. The GBD data may reflect death certificates that record more than one of the listed causes of death under study here, therefore leading to an overestimation of the cumulative totals. Without access to real-time mortality data on all causes, we are also unable to assess the ongoing effect of the pandemic on mortality related to other causes, such as cancer and cardiovascular disease, which may rise as healthcare resources have been both curtailed and diverted [17] . This analysis does not examine underlying comorbidities in people who died, which would provide further important perspectives for responding to the pandemic. Finally, morbidity from COVID-19 is clearly substantial but quantitative data in populations are not available and we were unable to replicate our work using morbidity data. Morbidity, both as a risk factor for mortality, and as a consequence of the infection is an important area for future research.

Our data from seven European countries provides an important public message for policymakers, healthcare workers and the public, who are trying to understand the impact of COVID-19 and the risk of dying. Other population-level studies have been conducted using UK data to contextualise these risks [18, 19] . Misinformation has been a problem, perpetuating public fear and anxiety, impacting on the increasing burden of adverse mental health during the pandemic and even contributing to suicide risk [20, 21] .

By presenting and interpreting population perspectives on mortality related to COVID-19 compared with other common causes of death, stratified by age and sex, we have provided perspectives to allow policymakers, professionals and the media to tailor both communications and interventions to manage the pandemic, including the level of anxiety and fear provoked by previously published mortality statistics, primarily daily and cumulative totals. Similar analyses are required globally and for the duration of the pandemic. More research is required to incorporate morbidity to produce a broader perspective on the true health impact of COVID-19 [15] .

None.

RB conceived the study. SB and JB developed the methodology, which was expanded by BO. BO carried out data extraction, which was checked independently by JB. BO carried out the data analysis. All authors contributed to the interpretation of the data. BO wrote the first draft of the manuscript, which was substantially edited by all authors. All authors approved the final version. All authors had access to the data and are responsible for data integrity and completeness.

None reported. 

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Witth€ oft, Health anxiety, cyberchondria, and coping in the current COVID-19 pandemic: which factors are related to coronavirus anxiety?

Anxiety on rise due to coronavirus, say mental health charities

Children's mortality from COVID-19 compared with all-deaths and other relevant causes of death: epidemiological information for decision-making by parents, teachers, clinicians and policymakers

Monitoring transmissibility and mortality of COVID-19 in Europe

Covid-19 worldwide: we need precise data by age group and sex urgently

Global burden of disease study

Demographics of COVID-19 deaths

Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study

COVID-19 zugzwang: potential public health moves towards population (herd) immunity

Impact of sex and gender on COVID-19 outcomes in Europe

SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes

Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis

Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data

Real estimates of mortality following COVID-19 infection

Three further ways that the COVID-19 pandemic will affect health outcomes

Scaling COVID-19 against inequalities: should the policy response consistently match the mortality challenge?

Use of "normal" risk to improve understanding of dangers of covid-19

First COVID-19 suicide case in Bangladesh due to fear of COVID-19 and xenophobia: possible suicide prevention strategies

Suicide risk and prevention during the COVID-19 pandemic